Richard W. Pascoe

Insider Reports History

Location
New York, NY
Signature
/s/ Michael Golembiewski, as attorney-in-fact for Richard W. Pascoe
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Richard W. Pascoe:

Company Role Class Num Shares Value Price $ Report Date Ownership
ZEVRA THERAPEUTICS, INC. Chief Executive Officer, Director Common Stock 29,973 $148,639 $4.96 09 Mar 2023 Direct
SEELOS THERAPEUTICS, INC. Director Stock Option (right to buy) 1,666 04 Jan 2024 Direct

Insider Reports Filed by Richard W. Pascoe

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000110465924002386-pascoe-richard-w-2024-01-04 SEELOS THERAPEUTICS, INC. 04 Jan 2024 1 $0 4 Director 08 Jan 2024, 21:46
ZVRA ZEVRA THERAPEUTICS, INC. 09 Mar 2023 1 +$41,978 4 Chief Executive Officer, Director 13 Mar 2023, 07:53
ZVRA KEMPHARM, INC 13 Jan 2023 1 +$51,679 4 Chief Executive Officer, Director 13 Jan 2023, 16:27
ZVRA KEMPHARM, INC 09 Jan 2023 1 $0 4 Chief Executive Officer, Director 11 Jan 2023, 20:46
/report/000113626123000008-pascoe-richard-w-2023-01-05 SEELOS THERAPEUTICS, INC. 05 Jan 2023 1 $0 4 Director 05 Jan 2023, 18:21
ZVRA KEMPHARM, INC 18 May 2022 7 +$24,608 4 Executive Chairman, Director 18 May 2022, 17:25
ZVRA KEMPHARM, INC 01 Feb 2022 1 $0 4 Executive Chairman, Director 03 Feb 2022, 16:14
/report/000113626122000021-pascoe-richard-w-2022-01-05 SEELOS THERAPEUTICS, INC. 05 Jan 2022 1 $0 4 Director 06 Jan 2022, 19:07
ZVRA KEMPHARM, INC 30 Nov 2021 1 +$11,822 4 Executive Chairman, Director 30 Nov 2021, 18:42
ZVRA KEMPHARM, INC 10 Nov 2021 1 $0 4 Executive Chairman, Director 10 Nov 2021, 20:26
ZVRA KEMPHARM, INC 17 Jun 2021 1 $0 4 Director 21 Jun 2021, 08:35